Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
No matter your politics, the stakes of the November midterm election are high.
It's going to decide control of Congress, the direction of the nation, perhaps even the fate of Donald Trump's presidency.
That said, the No. 1 issue for voters isn't any of that.
According to recent polls by NBC News/The Wall Street Journal and the Pew Research Center, it's healthcare.
Specifically, healthcare affordability.
After all, half of U.S. adults say that one large medical bill would force them to borrow money. One big medical bill could spell financial disaster for the majority of Americans. Today, 62% of bankruptcy filings are due to medical bills.
Problem is, there's no easy answer to this issue.
U.S. President Donald Trump and seemingly half the nation want to gut the Affordable Care Act (ACA), while the other half wants to go all the way to a single-payer system.
Given the nation's deep political divide, this would seem a terrible time to invest in healthcare. And overall, that's right.
But I believe you can make a bundle defying that sort of conventional wisdom.
That's why today I want to reveal a healthcare company that is actually addressing people's No. 1 issue by helping them reduce their healthcare costs.
And it's making its investors a ton of money by doing so.
In fact, it's beaten the market by 1,440% over the last year.
But it's not done yet – healthcare consumers are going to need its services for years to come, no matter what happens to the ACA.
That's why I believe it will double in the next two years.
Or sooner...
Premium Product = Premium Returns
I don't care what your politics are.
I don't care if you love Obamacare – or if you're rooting for its end.
Either way, you're here for the best investment opportunities I can find.
And the fact is that the health insurance management firm I'm about to tell you about is poised to deliver great earnings reports – and a soaring stock price – for years to come.
No matter what happens in November.
The 4 Cannabis Stocks to Buy Now – Profits of Up to 1,000% Could Be Likely This Election Year!
And that's because it offers health savings accounts (HSAs) – a premium (i.e., high deductible) health insurance management tool that both customers and employers love.
HSAs let you set aside money on a pretax basis to pay for their future healthcare needs – for deductibles, copayments, coinsurance, and other medical expenses. Because those dollars are untaxed and held in a savings account, you can lower your healthcare costs.
It's the sort of effective system that well-paid workers are willing to pay a premium for.
Employers love this program, too. Sponsoring a health plan with an attached HSA can save a company thousands of dollars per worker. Plus, it gives employees more doctor choices – and you get happier employees.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.
Thanks for the info… very interesting stuff…